Omeros Corporation (OMER) financial statements (2021 and earlier)

Company profile

Business Address 201 ELLIOTT AVENUE WEST
SEATTLE, WA 98119
State of Incorp. WA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:13561618445287
Cash and cash equivalents11363210
Short-term investments12458558043277
Other undisclosed cash, cash equivalents, and short-term investments 00(0)(0)00
Receivables43523171270
Inventory, net of allowances, customer advances and progress billings1100101
Inventory1100101
Prepaid expense  67221
Other current assets      0
Other undisclosed current assets117(0)00(0)(0)
Total current assets:1511049010860379
Noncurrent Assets
Operating lease, right-of-use asset2627
Property, plant and equipment10442111
Prepaid expense11     
Restricted cash and investments11166111
Other noncurrent assets     00
Other undisclosed noncurrent assets(8) 1    
Total noncurrent assets:3033687122
TOTAL ASSETS:18113796116674911
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33523626161614
Accounts payable4567365
Accrued liabilities2947301913107
Employee-related liabilities      2
Debt1410006
Other undisclosed current liabilities3     (2)
Total current liabilities:37553726161618
Noncurrent Liabilities
Long-term debt and lease obligation23619115184805026
Long-term debt, excluding current maturities23615814984805026
Finance lease, liability 2
Capital lease obligations2    
Operating lease, liability 31
Liabilities, other than long-term debt  899914
Deferred revenue and credits899914
Total noncurrent liabilities:23619115993895940
Total liabilities:2732461961191057559
Stockholders' equity
Stockholders' equity attributable to parent(121)(109)(100)(3)(37)(26)(43)
Common stock1100000
Additional paid in capital751625549520432377285
Accumulated deficit(873)(735)(650)(523)(470)(403)(328)
Total stockholders' equity:(121)(109)(100)(3)(37)(26)(43)
Other undisclosed liabilities and equity29     (5)
TOTAL LIABILITIES AND EQUITY:18113796116674911

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues74112306542141
Revenue, net16542141
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)(1)(1) 
Gross profit:73111296440121
Operating expenses(184)(174)(142)(109)(96)(85)(71)
Other undisclosed operating income  1111 
Operating loss:(111)(63)(112)(44)(54)(71)(70)
Nonoperating income (expense)122111(0)
Investment income, nonoperating   1110
Other nonoperating income (expense)122   (0)
Interest and debt expense(40)(23)(29)(11)(13)(5)(3)
Loss from continuing operations before income taxes:(150)(84)(140)(53)(67)(75)(74)
Income tax benefit12 13    
Net loss available to common stockholders, diluted:(138)(84)(127)(53)(67)(75)(74)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(138)(84)(127)(53)(67)(75)(74)
Comprehensive loss, net of tax, attributable to parent:(138)(84)(127)(53)(67)(75)(74)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: